Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Inovio Pharmaceuticals has reported a total revenue of $2.42m for the second quarter ended 30 June 2011, compared to $1.13m for the same period in 2010.
Subscribe to our email newsletter
Inovio Pharma’s net loss was $2.84m or $0.02 loss per diluted share, compared to $7.61m, or $0.07 per diluted share, for the same period in 2010.
The company’s loss from operations for the second quarter of 2011 was $5.14m, compared to $4.98m for the same period in 2010.
For the six months ended 30 June 2011, the company reported a total revenue of $5.53m, compared to $2.51m for the same period in 2010.
The company has reported net loss of $5.26m or 0.04 loss per diluted share for the six months ended 30 June 2011, as compared to $9.91m or $0.10 loss per diluted share for the same period in 2010.
Inovio Pharma’s loss from operations was $9.52m for the six months of 2011, compared to $9.38m for the same period in 2010.